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Background: Coronary artery calcium (CAC) testing is considered most useful for coronary heart disease (CHD) risk estimation primarily in 
“intermediate risk” individuals. We sought to determine prognostic significance and added predictive value of CAC in “low risk” women, in whom 
global risk factor scores are suboptimal.
method: We included women without diabetes and 10-year Framingham risk score (FRS) for CHD < 10% from the Multi-Ethnic Study of 
Atherosclerosis (MESA), Dallas Heart Study (DHS), Heinz Nixdorf Recall (HNR) study, and the Rotterdam Study. CAC score was classified into the 
following strata: 0, 1-10, 11-100, 101-300, > 300. The primary outcome was CHD, defined as nonfatal myocardial infarction and CHD death. We used 
Cox proportional hazards models to calculate multivariable-adjusted hazards ratios (HR) for CHD and calculated category-free net reclassification 
improvement (NRI) for addition of CAC to the baseline model containing study-specific coefficients for age, systolic blood pressure, total and HDL 
cholesterol, smoking, and antihypertensive medication. We used fixed-effects meta-analysis to combine effect measures.
results: In 6970 low-risk women (mean age 58 years), the prevalence of CAC was: MESA, 32% (N = 880); DHS, 42% (N = 496); HNR, 50% (N = 
908); Rotterdam, 73% (N = 949). Over 8 years of follow up, the CHD event rate in women with no CAC ranged from 0.3% (DHS) to 1.2% (Rotterdam); 
the event rate in women with CAC > 0 ranged from 1.0% (DHS) to 3.3% (Rotterdam). Multivariable-adjusted HRs for CHD in women with any CAC 
compared to women without CAC ranged from 1.64 (0.65-4.13, HNR) to 2.08 (0.72-6.02, Rotterdam). The HR for CHD from meta-analysis was 1.85 
(1.12-3.04). The HR from meta-analysis for CHD in women with CAC > 300 compared to women with no CAC was 6.48 (3.07-13.67). The NRI with 
addition of prevalent CAC to the baseline model ranged from 0.27 (Rotterdam) to 0.61 (DHS), and was 0.37 (P < 0.001) for the meta-analysis. When 
CAC strata were added to the baseline model instead of CAC presence, the NRI from meta-analysis was 0.50 (P < 0.001).
conclusion: In low-risk women from four large cohorts, CAC presence was associated with incident CHD and improved risk classification for CHD.
